General Atlantic LLC
- SEC CIK
- 0001017645
- Latest filing
- Aug 14, 2026
Holdings in Q4 2025
Holdings as of Dec 31, 2025, filed Feb 17, 2026. Long positions only; changes compare share counts with Q3 2025.
- Positions
- 13
- −3 vs. Q3 2025
- Portfolio value
- $2.87B
- −$458.1M (−13.8%) vs. Q3 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DLOdLocal Ltd | CLASS A COM | 46,656,695 | $659.7M | 23.0% | 00.0% | Unchanged | History |
| CHYMChime Financial, Inc. | COM SHS CL A | 21,259,683 | $535.1M | 18.6% | +2,050,923+10.7% | Added | History |
| XPXP Inc. | CL A | 22,699,133 | $371.6M | 12.9% | −2,818,600−11.0% | Reduced | History |
| ALKTAlkami Technology, Inc. | Stock | 11,991,480 | $276.6M | 9.6% | 00.0% | Unchanged | History |
| ALHCAlignment Healthcare, Inc. | COM | 13,167,733 | $260.1M | 9.1% | −11,119,494−45.8% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 2,812,928 | $224.0M | 7.8% | +338,500+13.7% | Added | History |
| PHVSPharvaris N.V. | COM | 8,031,252 | $222.9M | 7.8% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 6,117,715 | $153.0M | 5.3% | −3,564,103−36.8% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 4,897,159 | $92.9M | 3.2% | +4,897,159 | New | History |
| EWCZEuropean Wax Center, Inc. | CLASS A COM | 13,110,492 | $47.2M | 1.6% | 00.0% | Unchanged | History |
| RSKDRiskified Ltd. | SHS CL A | 5,324,998 | $26.5M | 0.9% | 00.0% | Unchanged | History |
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 2,474,859 | $2.72M | 0.1% | 00.0% | Unchanged | History |
| BULLWebull Corp | ORD SHS | 50,816 | $394.8K | <0.1% | −7,148,051−99.3% | Reduced | History |
Sold out since Q3 2025 (4)
Positions held at the end of Q3 2025 that are gone from this filing.
| Security | Class | Shares in Q3 2025 | Value in Q3 2025 | % of portfolio in Q3 2025 | History |
|---|---|---|---|---|---|
| AKROAkero Therapeutics, Inc. | COM | 5,733,989 | $272.2M | 8.2% | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 1,500,000 | $52.9M | 1.6% | History |
| ADAGAdagene Inc. | ADS | 3,782,339 | $7.53M | 0.2% | History |
| ALMSAlumis Inc. | COM | 1,297,530 | $5.18M | 0.2% | History |